Sarepta Therapeutics, Inc. (SRPT) was founded in 1980 and is based in Cambridge, Massachusetts. The company is focused on developing RNA-based therapeutics and gene therapy against Duchenne muscular ...
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. A gene therapy technique restored some muscle function for months in patients with a certain type of muscular ...
In a world obsessed with achieving peak physical performance, men are constantly on the lookout for ways to enhance their strength and performance. Enter the Alpha Strength supplement from New Alpha ...
- BridgeBio will also share 15-month Phase 2 data and review the Phase 3 clinical trial design of BBP-418, a potential therapeutic for patients with LGMD2I, with initiation of its Phase 3 study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback